missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human ARL4D (aa 1-35) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (100%), Rat (100%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-63851 (PA5-63851. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
ADP-ribosylation factor 4D is a member of the ADP-ribosylation factor family of GTP-binding proteins. ARL4D is closely similar to ARL4A and ARL4C and each has a nuclear localization signal and an unusually high guanine nucleotide exchange rate. This protein may play a role in membrane-associated intracellular trafficking. Mutations in this gene have been associated with Bardet-Biedl syndrome.
Specifications
Specifications
| Accession Number | P49703 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 379 |
| Name | Human ARL4D (aa 1-35) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 1110036H21Rik; ADP ribosylation factor like GTPase 4 D; ADP-ribosylation factor like GTPase 4 D; ADP-ribosylation factor-like 4 D; ADP-ribosylation factor-like 5; ADP-ribosylation factor-like 6; ADP-ribosylation factor-like protein 4 D; ADP-ribosylation factor-like protein 4 L; ADP-ribosylation factor-like protein 5; Arf4l; Arfl4; ARL4D; Arl5; ARL6; AW456149; neuroprotective protein 2 |
| Common Name | ARL4D |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction